SCHEMBL21148601

SCHEMBL21148601

c1cc(-c2nc(-c3ccc(-c4cccc5sc6ccccc6c45)cc3)nc(-c3cccc4sc5ccccc5c34)n2)cc(-c2cccc3sc4ccccc4c23)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LIMK1 P53667 1/20 0.39
ALOX5 P09917 1/20 0.38
F9 P00740 1/20 0.35
SLC9A1 P19634 3/20 0.34
GPR3 P46089 1/20 0.34
BRDT Q58F21 1/20 0.34
ADORA2A P29274 2/20 0.33
ADORA1 P30542 2/20 0.33
TSHR P16473 2/20 0.33
ADORA3 P0DMS8 1/20 0.33
ALOX15 P16050 1/20 0.33
ADORA2B P29275 1/20 0.33
ALDH1A1 P00352 4/20 0.33
MAPT P10636 4/20 0.33
HPGD P15428 4/20 0.33
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
KDM4E B2RXH2 2/20 0.32
ATM Q13315 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21149147 0.96 LIMK1 (0.38) LIMK1ALOX5F9SLC9A1GPR3
SCHEMBL26503661 0.96 LIMK1 (0.42) LIMK1ALOX5F9SLC9A1GPR3
SCHEMBL24266637 0.96 LIMK1 (0.39) LIMK1ALOX5F9SLC9A1GPR3
SCHEMBL21148248 0.96 LIMK1 (0.38) LIMK1ALOX5F9SLC9A1GPR3
SCHEMBL26503666 0.95 LIMK1 (0.40) LIMK1ALOX5F9SLC9A1GPR3
SCHEMBL26503663 0.95 LIMK1 (0.41) LIMK1ALOX5F9SLC9A1GPR3
SCHEMBL26503665 0.93 LIMK1 (0.40) LIMK1ALOX5F9SLC9A1ADORA2A
SCHEMBL21563853 0.93 LIMK1 (0.39) LIMK1ALOX5F9SLC9A1GPR3
SCHEMBL21148707 0.93 LIMK1 (0.39) LIMK1ALOX5F9SLC9A1GPR3
SCHEMBL21148194 0.93 LIMK1 (0.39) LIMK1ALOX5F9SLC9A1GPR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230329097-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO LTD (KR) 2023-10-12 US disclosed
US-20230329097-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO LTD (KR) 2023-10-12 US disclosed
US-20190214573-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2019-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190214573-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE OR10J3, OCIAD2, OCIAD1 LIMK1 133/4885ALOX5 306/4885F9 479/4885
US-20230329097-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE OR10J3, OCIAD2, OCIAD1 LIMK1 133/4885ALOX5 306/4885F9 479/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.